Abstract
Multiple glycoproteins of human cytomegalovirus (HCMV) encoded by the genes US2, US3, US6 and US11 interrupt the MHC class I pathway of antigen presentation at distinct checkpoints to avoid recognition of infected cells by cytotoxic CD8+ T lymphocytes. The action of cytokines like interferon (IFN)-γ, IFN-α/β and tumour necrosis factor α (TNF-α) compensate for the viral inhibition and restore antigen presentation in HCMV-infected cells. This finding was explained by their effects on cellular rather than viral genes and reflected by an increase in the production, assembly and maturation of MHC class I molecules resulting in an escape of MHC I from viral control. Here we reproduce the IFN-γ-mediated effect when MHC I-subversive gene functions of HCMV are tested in isolation, but the efficacy of IFN-γ to restore MHC I surface expression in US2-, US6- and US11-transfectants differs significantly. In addition, in HCMV-infected cells IFN-γ strongly affects the synthesis of the US6-encoded glycoprotein. Despite the capability of HCMV to block the interferon signaling pathway the IFN-γ driven enhancement of MHC class I and class II expression remains effective provided that cells are exposed to IFN-γ before infection. Our findings illustrate a complex interplay between host immune factors and viral immune evasion functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchison III C.A., Kouzarides T., Martignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., and Barreil B.G., Curr Top Microbiol Immunol 54, 125–169, 1990.
Rawlinson W.D., Farrell H.E., and Barrell B.G., J Virol 70, 8833–8849, 1996.
Reddehase M.J., Weiland F., Münch K., Jonjic S., Lüske A., and Koszinowski U.H., J Virol 55, 264–273, 1985.
Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., and Greenberg P.D., Science 257, 238–241, 1992.
Koopmann J.O., Hämmerling G.J., and Momburg F., Curr Opin Immunol 9, 80–88, 1997.
Sadasivan B., Lehner P.J., Ortmann B., Spies T., and Cresswell P., Immunity 5, 103–114, 1996.
Ortmann B., Copeman J., Lehner P.J., Sadasivan B., Herberg J.A., Grandea A.G., Riddell S.R., Tampe R., Spies T., Trowsdale J., and Cresswell P., Science 277, 1306–1309, 1997.
Williams D.B., Vassilakos A., and Suh W.-K., Trends Cell Biol 6, 267–273, 1996.
Del Val M., Münch K., Reddehase M.J., and Koszinowski U.H., Cell 58, 305–315, 1989.
Campbell A.E., Slater J.S., Cavanaugh V.J., and Stenberg R.M., J Virol 66, 3011–3017, 1992.
Warren A.P., Ducroq D.H., Lehner P.J., and Borysiewicz L.K., J Virol 68, 2822–2829, 1994.
Hengel H., Eßlinger C, Pool J., Goulmy E., and Koszinowski U.H., J Gen Virol 76, 2987–2997, 1995.
Browne H., Smith G., Beck S., and Minson T., Nature 347, 770–772, 1990.
Beersma M.F.C., Bijlmakers M.J.E., and Ploegh H.L., J Immunol 151, 4455–4464, 1993.
Yamashita Y., Shimokata K., Mizuno S., Yamaguchi H., and Nishiyama Y., Virology 193, 727–736, 1993.
Del Val M., Hengel H., Häcker H., Hartlaub U., Ruppert T., Lucin P., and Koszinowski U.H., J Exp Med 772, 729–738, 1992.
Hengel H. and Koszinowski U.H., Curr Opin Immunol 9, 470–476, 1997.
Ziegler H., Thäle R., Lucin P., Muranyi W.H., Flohr T., Hengel H., Farell H., Rawlinson W., and Koszinowski U.H., Immunity 6, 57–66, 1997.
Kleijnen M., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A., Koszinowski U.H., Hill A.B., and Ploegh H.L., EMBO J 16, 685–694, 1997.
Jones T.R., Hanson L.K., Sun L., Slater J.S., Stenberg R.S., and Campbell A.E., J Virol 69, 4830–4841, 1995.
Hengel H., Flohr T., Hämmerling G.J., Koszinowski U.H., and Momburg F, J Gen Virol 77, 2287–2296, 1996.
Wiertz E.J.H.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., and Ploegh H.L., Cell 84, 769–779, 1996.
Wiertz E.J.H.J., Tortorella D., Bogyo M., Yu J., Mothes W, Jones T.R., Rapoport TA., and Ploegh H.L., Nature 384, 432–438, 1996.
Jones T.R., and Sun L., J Virol 71, 2970–2979, 1997.
Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y, and Früh K., Proc Natl Acad Sci USA 93, 10990–10995, 1996.
Jones T.R., Wiertz E.J.H.J., Sun L., Fish K.N., Nelson J.A., and Ploegh H.L., Proc Natl Acad Sci USA 93, 11327–11333, 1996.
Hengel H., Koopmann J.O., Flohr T., Muranyi W., Goulmy E., Hämmerling G.J., Koszinowski U.H., and Momburg F., Immunity 6, 623–632, 1997.
Ahn K., Grimier A., Galocha B., Jones T.R., Wiertz E.J.H.J., Ploegh H.L., Peterson P.A., and Früh K., Immunity 6, 613–621, 1997.
Lehner P.J., Karttunen J., Wilkinson G.W.G., and Cresswell P., Proc Natl Acad Sei USA 94, 6904–6909, 1997.
Kollert-Jöns A., Bogner E., and Radsak K., J Virol 65, 5184–5189, 1991.
Tortorella D., Story CM., Huppa J.B., Wiertz E.J.H.J., Jones T.R., and Ploegh H.L., J Cell Biol 142, 365–376, 1998.
Plemper R.K., Bömler S., Bordallo J., Sommer T., and Wolf D.H., Nature 388, 891–895, 1997.
Thrower A.R., Bullock G., Bissell J.E., and Stinski M.F., J Virol 70, 91–100, 1996.
Maijdji E., Tugizov S., Jones T, Zheng Z., and Pereira L., J Virol 70, 8402–8410, 1996.
Jones T.R. and Muzithras VP, J Virol 65, 2024–2036, 1991.
Machold R., Wiertz E.J.H.J., Jones T, and Ploegh H.L., J Exp Med 185, 363–366, 1996.
Schust D.J., Tortorella D., Seebach J., Phan C, and Ploegh H.L., J Exp Med 188, 497–503, 1998.
Hengel H., Lucin P., Jonjic S., Ruppert T, and Koszinowski U.H., J Virol 68, 289–297, 1994.
Lucin P., Jonjic S., Messerle M., Polie B., Hengel H., and Koszinowski U.H., J Gen Virol 75, 101–110, 1994.
Pestka S., Langer J.A., Zoon K.C., and Samuel E.C., Ann Rev Biochem 56, 727–777, 1987.
Wong G.H.W, Clark-Lewis I., McKimm-Breschkin J.L., Harris A.W., and Schrader J.W., J Immunol 131, 788–793, 1983.
Collins T., Lapierre L.A., Fiers W., Strominger J.L., and Pober J.S., Proc Natl Acad Sci USA 83, 446–450, 1986.
Ortiz-Navarrete V., Seelig A., Gernold M., Frentzel S., Kloetzel P.M., and Hämmerling G.J., Nature 353, 662–664, 1991.
Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman W.J., and Sedmak D.D., J Exp Med 187, 675–683, 1998.
Heise M., Connick M., and Virgin H.W., J Exp Med 187, 1037–1046, 1998.
Geginat G., Ruppert T., Hengel H., Holtappels R., and Koszinowski U.H., J Immunol 158, 3303–3310, 1997.
Flomenberg P., Piaskowki V., Truitt R., and Casper J.T., J Virol 70, 6314–6322, 1996.
Tigges M.A., Leng S., Johnson D.C., and Burke R.L., J Immunol 156, 3901–3910, 1996.
Darnell J.E., Kerr I.M., and Stark G.R., Science 264, 1415–1421, 1994.
O’Shea J.J., Immunity 7, 1–11, 1997.
Miller D.M., Rahill B.M., Waldman W.J., and Sedmak D.D., 23rd International Herpesvirus Workshop. York 1998, poster no.363.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Benz, C., Hengel, H. (2000). MHC Class I-Subversive Gene Functions of Cytomegalovirus and their Regulation by Interferons-an Intricate Balance. In: Becker, Y., Darai, G. (eds) Molecular Evolution of Viruses — Past and Present. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1707-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1707-8_4
Received:
Accepted:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5688-2
Online ISBN: 978-1-4615-1707-8
eBook Packages: Springer Book Archive